1. PRODUCT NAME 2. QUALITATIVE AND …
NEW ZEALAND DATA SHEET Clomazol 2% Vaginal Cream Clomazol 1% Vaginal Cream Clomazol 1% Topical Cream Page 1 of 8. 1. PRODUCT NAME . Clomazol 2% vaginal cream (3 day treatment)
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
What You Should Know About Vaginal Atrophy
www.drcarolmeynen.comvagina with your fingers or an applicator, or spread them on the vulva (the vaginal lips and skin outside the vaginal entrance). Vaginal Lubricants.—The products are also
Instructions for Using Vaginal Misoprostol in …
prochoice.orgInstructions for Using Vaginal Misoprostol in Medical Abortion Some women bleed after taking mifepristone. However, in almost all cases you …
The new Gentle Comfort™ Vaginal Cream Applicator
www.gentlecomfort.comPick-up of vaginal detrius is reduced, or eliminated. Contact surfaces of the new applicator are easily reached and cleaned. It therefore is much more hygienic to use
Applicator, Comfort, Cream, Vaginal, Gentle comfort vaginal cream applicator, Gentle
HEALTH PROFESSIONAL GUIDELINE - MEDLAB …
www.medlabcentral.co.nzHEALTH PROFESSIONAL GUIDELINE INTRODUCTION From 4 December 2017 the handling of non-molecular vaginal swabs, by the Microbiology department, will
Health, Guidelines, Professional, Vaginal, Health professional guideline
OVESTIN CREAM - Medsafe
www.medsafe.govt.nzOne epidemiological study has shown that long-term treatment with low doses of oral oestriol, but not vaginal oestriol, may increase the risk for endometrial cancer.
VAGINAL BREECH DELIVERY - DUE East Lancashire
www.eastlancsdue.nhs.ukVAGINAL BREECH DELIVERY Eileen Whitehead 2010 East Lancashire Hospitals NHS Trust
Cervix Cancer 101 - Home - NCCC
www.nccc-online.orgCervix Cancer 101 Lois M Ramondetta M.D. Professor Gynecologic Oncology MD Anderson Cancer Center Chief , Division of Gynecologic …